25E-NBOMe Stats & Data
COc1ccccc1CNCCc1cc(OC)c(CC)cc1OCPXDVGFGXPVCNAB-UHFFFAOYSA-NPharmacology
DrugBankHistory & Culture
25E-NBOMe first appeared in scientific literature around 2012, emerging as part of the broader NBOMe series of substituted phenethylamines. This class of compounds, which includes related substances such as 25I-NBOMe and 25C-NBOMe, gained attention during this period as novel psychoactive substances. Following its initial scientific documentation, 25E-NBOMe subsequently appeared on the recreational drug market alongside other members of this chemical family.
Effect Profile
Curated + 3 ReportsModerate body load with mild visuals, low headspace
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Acute tolerance: develops within a single session — the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Cross-Tolerances
Experience Report Analysis
ErowidDemographics
Gender Distribution
Age Distribution
Reports Over Time
Effect Analysis
ErowidEffects aggregated from 3 experience reports (3 Erowid)
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 1
Adverse Effects 1
Real-World Dose Distribution
62K DosesFrom 5 individual dose entries
Form / Preparation
Most common forms and preparations reported
Legal Status
| Country | Status | Notes |
|---|---|---|
| Sweden | Narcotic substance | Classified as a narcotic substance by Sweden's public health agency on January 18, 2019. This classification places it under the same regulatory framework as other controlled narcotics in Swedish law. |
| United Kingdom | Class A | Controlled under the Misuse of Drugs Act 1971 through the N-benzylphenethylamine catch-all clause. Class A substances carry the most severe penalties, with possession punishable by up to 7 years imprisonment and supply offenses carrying maximum life sentences. |